Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Summer;8(3):165-8.

Spurious hypocalcemia after gadodiamide-enhanced magnetic resonance imaging: a case report and review of the literature

Case Reports

Spurious hypocalcemia after gadodiamide-enhanced magnetic resonance imaging: a case report and review of the literature

Christopher D Moore et al. Rev Urol. 2006 Summer.

Abstract

Gadolinium-enhanced magnetic resonance imaging is a diagnostic modality widely used in urologic practice. We report on a 54-year-old woman in whom a critically low serum calcium level was measured with standard colorimetric assay after gadodiamide-enhanced magnetic resonance imaging. The same phenomenon was noted in 2 other patients seen in our practice. Repeat serum calcium measurements performed several hours later were within normal limits. Commercially available gadolinium-based contrast agents might precipitate critically low serum calcium values when measured by standard colorimetric assay. Physician awareness of gadodiamide-induced spurious hypocalcemia might prevent unnecessary therapeutic interventions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Tombach B, Bremer C, Reimer P, et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology. 2001;218:651–657. - PubMed
    1. Runge VM. Safety of magnetic resonance contrast media. Top Magn Reson Imaging. 2001;12:309–314. - PubMed
    1. Prince MR, Arnoldus C, Frisoli JF. Nephrotoxicity of high-dose gadolinium compared to iodinated contrast. J Magn Reson Imaging. 1996;6:162–166. - PubMed
    1. Muroff LR. MRI contrast: current agents and issues. Appl Radiol. 2001;30(suppl):5–7.
    1. Prince MR. More on pseudohypocalcemia and gadolinium-enhanced MRI. N Engl J Med. 2004;350:87–88. - PubMed

Publication types

LinkOut - more resources